The aim of our program is to develop a novel approach to discovering molecular mechanism in biology, chemical genetics, and to change shape; and vesicle trafficking, the study of how cells selectively import and export proteins in different compartments. For both of these biological areas, chemical tools are particularly important because the events we wish to study happen in seconds or minutes, and most other methods of study are slow. The chemical genetics approach aims to emulate classical genetics as a discovery tool, by using chemicals that alter the functions of specific proteins as a way to understand the functions of these proteins. In particular, we want to use chemicals to identify new proteins, not previously known to be important in the function of the cytoskeleton or in vesicle trafficking. We therefore plan to accumulate large collections of chemicals (chemical libraries) and use high-throughput screening to identify chemicals that interfere with these processes, and only then identify the proteins that the chemicals bind to. In parallel, we will screen for inhibitors of active chemicals to share with the whole scientific community. In Projects 1 and 2, we will discover chemicals that inhibit cell migration and several key proteins involved in formation and function of the cytoskeleton. In Project 3, we will identify novel inhibitors of in-bound and out-bound vesicle traffic. In Project 4, we will develop new methods for identifying the targets of those chemicals, and new ways to assess the usefulness of a chemical library for biological screening. In Project 5, we will construct a chemical library patterned after alkaloids, which we expect to be a rich source of biologically active chemicals. Three Cores will support this work: Core A will provide administrative support, Core B will make the screening and database functions of the Program possible, and Core C will support all projects with synthetic chemistry expertise.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM062566-05
Application #
6801517
Study Section
Special Emphasis Panel (ZRG1-CDF-2 (01))
Program Officer
Rodewald, Richard D
Project Start
2000-09-30
Project End
2006-08-31
Budget Start
2004-09-01
Budget End
2006-08-31
Support Year
5
Fiscal Year
2004
Total Cost
$1,498,111
Indirect Cost
Name
Harvard University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Boucrot, Emmanuel; Howes, Mark T; Kirchhausen, Tomas et al. (2011) Redistribution of caveolae during mitosis. J Cell Sci 124:1965-72
Kirchhausen, Tom; Macia, Eric; Pelish, Henry E (2008) Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis. Methods Enzymol 438:77-93
Boucrot, Emmanuel; Kirchhausen, Tomas (2008) Mammalian cells change volume during mitosis. PLoS One 3:e1477
Saffarian, Saveez; Kirchhausen, Tomas (2008) Differential evanescence nanometry: live-cell fluorescence measurements with 10-nm axial resolution on the plasma membrane. Biophys J 94:2333-42
Ingolia, Nicholas T; Murray, Andrew W (2007) Positive-feedback loops as a flexible biological module. Curr Biol 17:668-77
Boucrot, Emmanuel; Kirchhausen, Tomas (2007) Endosomal recycling controls plasma membrane area during mitosis. Proc Natl Acad Sci U S A 104:7939-44
Goess, Brian C; Hannoush, Rami N; Chan, Lawrence K et al. (2006) Synthesis of a 10,000-membered library of molecules resembling carpanone and discovery of vesicular traffic inhibitors. J Am Chem Soc 128:5391-403
Boucrot, Emmanuel; Saffarian, Saveez; Massol, Ramiro et al. (2006) Role of lipids and actin in the formation of clathrin-coated pits. Exp Cell Res 312:4036-48
Pelish, Henry E; Peterson, Jeffrey R; Salvarezza, Susana B et al. (2006) Secramine inhibits Cdc42-dependent functions in cells and Cdc42 activation in vitro. Nat Chem Biol 2:39-46
Macia, Eric; Ehrlich, Marcelo; Massol, Ramiro et al. (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10:839-50

Showing the most recent 10 out of 24 publications